Table 1 Efficacy of onabotulinumtoxinA 195 U.
From: O068. A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine
| Â | baseline | 3 m | 6 m | 9 m | 12 m | 15 m | 18 m | 21 m | 24 m |
|---|---|---|---|---|---|---|---|---|---|
Headache days | 22.2 | -8.1 | -12 | -14.7 | -16.5 | -16.8 | -17.2 | -17.7 | -18.1 |
Migraine days | 21.6 | -7.3 | -10.4 | -13.1 | -15.9 | -16.7 | -17 | -17.5 | -17.6 |
Acute pain medication intake days | 21 | -7.1 | -11.1 | -13.8 | -15.7 | -16 | -16.2 | -17 | -17.3 |
HIT-6 score | 67.9 | -- | -7 | -- | -11.1 | -- | -13.9 | -- | -19 |